This secondary analysis of predominantly lung cancer patients , consistent with the original analysis , shows no survival advantage for the group overall when treated with WBRT and SRS ; however , in patients with high GPA ( 3.5-4 ) , there is a survival advantage regardless of whether they have 1 , 2 , or 3 BM .